Finally, cross-species conservation of integrin signaling pathways (Cooper and Giancotti, 2019) and YAP/TAZ activity (Sebé-Pedrós et al., 2012) makes Drosophila tumor models ideal for exploring peptide and combinatorial therapeutic strategies for YAP-driven cancers. This evidence concerns the gene YAP1 and cancer.